Harpoon Therapeutics 13G Filing Shows Commodore Capital LP Reported 9.9% Stake In Co As Of October 25, 2023
Portfolio Pulse from Benzinga Newsdesk
Commodore Capital LP has reported a 9.9% stake in Harpoon Therapeutics, according to a 13G filing with the SEC. The stake was reported as of October 25, 2023.
November 03, 2023 | 8:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Commodore Capital LP's 9.9% stake in Harpoon Therapeutics could potentially influence the company's stock price.
The acquisition of a significant stake by Commodore Capital LP could potentially influence Harpoon Therapeutics' stock price. However, the direction of the impact is uncertain without additional information on Commodore Capital's intentions or market reaction.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100